We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cambridge Nutritional Sciences Plc | LSE:CNSL | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.70 | 321 | 07:33:37 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3.40 | 4.00 | 3.70 | 3.70 | 3.70 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 9.77M | -231k | -0.0010 | -37.00 | 8.8M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 11:44:18 | O | 270 | 3.475 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 06/2/2025 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Director/PDMR Shareholding |
| 30/1/2025 | 09:41 | UK RNS | Cambridge Nutritional Sciences PLC Director/PDMR Shareholding |
| 21/1/2025 | 19:22 | ALNC |  Cambridge Nutritional and Novacyt note subsidiary related legal action |
| 21/1/2025 | 16:03 | UK RNS | Cambridge Nutritional Sciences PLC Omega Diagnostics court summons |
| 16/1/2025 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Settlement of DHSC Claim |
| 07/1/2025 | 17:25 | UK RNS | Cambridge Nutritional Sciences PLC Holding(s) in Company |
| 07/1/2025 | 17:20 | UK RNS | Cambridge Nutritional Sciences PLC Holding(s) in Company |
| 04/12/2024 | 13:33 | UK RNS | Cambridge Nutritional Sciences PLC Holding(s) in Company |
| 04/12/2024 | 13:32 | UK RNS | Cambridge Nutritional Sciences PLC Holding(s) in Company |
| 21/11/2024 | 15:47 | ALNC | Cambridge Nutritional Sciences interim loss narrows as costs decrease |
Cambridge Nutritional Sc... (CNSL) Share Charts1 Year Cambridge Nutritional Sc... Chart |
|
1 Month Cambridge Nutritional Sc... Chart |
Intraday Cambridge Nutritional Sc... Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 06/2/2025 | 15:47 | Cambridge Nutritional Sciences: Ex Omega Diagnostics (ODX) | 517 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 09/2/2025 08:20 by Cambridge Nutritional Sc... Daily Update Cambridge Nutritional Sciences Plc is listed in the Offices-holdng Companies,nec sector of the London Stock Exchange with ticker CNSL. The last closing price for Cambridge Nutritional Sc... was 3.70p.Cambridge Nutritional Sc... currently has 237,950,660 shares in issue. The market capitalisation of Cambridge Nutritional Sc... is £8,804,174. Cambridge Nutritional Sc... has a price to earnings ratio (PE ratio) of -37.00. This morning CNSL shares opened at 3.70p |
Posted at 27/1/2025 11:23 by yasxii GentlemenThe Gracious Fellow points out that the last RNS was hardly worthy of delivery to the market, a good CEO would have blocked it, instead we have a rather wet behind the ears fellow who probably knows no better, this is not to suggest Cooper is poor from a hands on business perspective, he has clearly delivered significant profitability and margin increase. Moving on it is worth pointing out that Cavendish (broker) have not even bothered to review the court summons, as the above poster points out the charge (which is a minuscule affair in any-case) effects a third party. Once again for the benefit of doubt the Gracious Fellow is long Cambridge and would add that market dynamics will move the share price significantly in due course. Also note the recent sector M&A activity which has been priced way above market levels. CNSL is a BUY. |
Posted at 26/1/2025 20:49 by thecoyone Those who sold on the rather irrelevant RNS will be kicking themselves, CNSL have only been summoned to attend court proceedings, in actual fact it is Novacyt (NCYT) who have actually been charged.The matter is broadly irrelevant to CNSL, at the very worst a very modest fine might occur, although extremely unlikely. The share price hit 4.2p bid on the 17th, you can now buy in at 3.7p, I have a feeling a few sold out on the dynamic move from 2.8p to 4.3p mid price however the indicators remain exceptionally bullish. Broker target remains at 10p. |
Posted at 16/1/2025 12:15 by thecoyone Cavendish have commented today on the settlement, suggesting the conclusion leaves the way open for share price appreciation.....'We believe the uncertainty surrounding the DHSC case had created a significant unfortunate overhang on the share price and, with its successful positive resolution, provides the constructive clarity investors had been anticipating. With the balance sheet now unburdened, we believe CNS is well-positioned to capitalise on its strong cash reserves and forecasted FY25 growth in adj. EBITDA profitability. With the stock currently trading on an FY1 EV/Sales of just 0.2x, we believe this represents compelling value, considering the level of growth potential that could be unlocked from the fast-growing and lucrative food-sensitivity testing market, which appears to be notably gaining increased mainstream market acceptance' |
Posted at 15/1/2025 08:29 by kingston78 A problem with this share is that as soon as there is light selling MM drops the share price substantially and with a wide spread. I expect to hear a good trading update. Hopefully, the share price rises with a narrow spread. |
Posted at 07/1/2025 10:47 by kingston78 Rarely do we see so much cash and no debt in an AIM company. Strip out the cash and you will have a growth business valued at little. That's why sometimes it is wise for the directors to distribute surplus cash as a special dividend, actually enhancing the share price and benefiting all shareholders.I bet that if even 1 p worth per share is distributed as a special dividend, the share price will not drop at all. |
Posted at 06/1/2025 12:56 by kingston78 In the weekly candle chart I can see three "white marching soldiers". This is a very bullish sign. The relative strength indicator is ticking up. Moreover, the MACD (a reliable indicator) has crossed from negative to positive. All these technical indicators and the fundamentals will surely propel the share price higher. My immediate first target is 3.6 p.The company should distribute the surplus cash as special dividend to shareholders, and see the share price also moving up higher. |
Posted at 05/1/2025 22:24 by one2go This is worth a read....Gentlemen The Gracious Fellow has perused the recent results and wishes to comment. Cambridge is performing excellently from an operational perspective, the slight fall in revenue for the HY has been explained, it is due to operational improvement leading to buyers destocking due to Cambridge being able to supply on time with confidence, this is a one off situation. Moving ahead the company anticipates a strong second half. The Gracious Fellow notes the ongoing apparent share price manipulation by a plethora of tiny sell trades across each trading day, aim being to depress the share price and quell sentiment, in the meantime large buys appear after hours, make of it what you will. The current EV of CNSL sits at a pathetic £2m which makes the company a very juicy candidate for takeover. According to Cavendish CNSL will end the year with a £5m cash balance, currently Cambridge is valued at £6.75m. Readers may wish to take advantage of the weak share price, one cannot rule out a bid pitched way beyond current levels. |
Posted at 17/12/2024 09:35 by yasxii GentlemenThe Gracious Fellow has perused the recent results and wishes to comment. Cambridge is performing excellently from an operational perspective, the slight fall in revenue for the HY has been explained, it is due to operational improvement leading to buyers destocking due to Cambridge being able to supply on time with confidence, this is a one off situation. Moving ahead the company anticipates a strong second half. The Gracious Fellow notes the ongoing apparent share price manipulation by a plethora of tiny sell trades across each trading day, aim being to depress the share price and quell sentiment, in the meantime large buys appear after hours, make of it what you will. The current EV of CNSL sits at a pathetic £2m which makes the company a very juicy candidate for takeover. According to Cavendish CNSL will end the year with a £5m cash balance, currently Cambridge is valued at £6.75m. Readers may wish to take advantage of the weak share price, one cannot rule out a bid pitched way beyond current levels. |
Posted at 19/11/2024 08:07 by silverspoon2009 Re-rate only a matter of time.There were some chunky buy trades yesterday including one for nearly 600,000 shares or £20k. In the past, as others have pointed out, the share price has risen strongly ahead of the last 3 results statements (all were good) so I suspect there may be some leaks as the documents are passed around various city houses for checking/sign offs etc. Everything about this outfit has been positive since they focussed entirely on Health/Nutrition with excellent performance operationally. What will it take to move the share price into a new range, I suspect forward forecasts, that is just what is about to come if you listen to the last live media event. It can be listened to here, the Q&A session is at the end which reveals a lot. |
Posted at 19/7/2024 07:42 by kingston78 Recently there have been large volumes of trading in some hot small cap stocks, pushing some of them up by over 100% or more quickly.The share chart of CNSL is rising again, and if the mid-price at 4 p holds the share will push upwards towards 5 and 6 p quickly. A barrier is difficult to break, but once broken, there is a quantum leap. I hope that the share price after the announcement of result and investors presentation will double to 8 p. I have also noticed that some traders rotate by targeting to push up one or two stocks and then hunt another target. I hope that they will land on here to push up the share price of CNSL. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
